FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing a compound of formula (II) or a stereoisomer or salt thereof, where each of R1a and R1b is independently hydrogen, halogen or unsubstituted C1-3alkyl; each R2 is independently halogen or unsubstituted C1-3alkyl; m is 0, 1 or 2; and n is 1, 2 or 3; wherein the method includes: (a) contacting a compound of formula (III) or a stereoisomer or salt thereof with an acid selected from H2SO4 or ClSO3H to form a compound of formula (IIIa) or a stereoisomer or salt thereof, (b) contacting a compound of formula (IIIa) or a stereoisomer or salt thereof with a hydroxide base to form a compound of formula (IV) or a stereoisomer or salt thereof, (c) hydrogenation of a compound of formula (IV) or a stereoisomer or salt thereof, in the presence of a catalyst, to form a compound of formula (V) or a stereoisomer or salt thereof and contacting a compound of formula (V) or a stereoisomer or salt thereof with a compound of formula (VI), thereby forming a compound of formula (II) or a stereoisomer or salt thereof. Invention also relates to methods of producing compounds of formula (I) and (1).
EFFECT: novel method of producing substituted condensed tricyclic compounds, including GDC-9545, and intermediate compounds with high output, characterized by improved process conditions and scalability.
23 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
MMPL3 INHIBITORS, COMPOSITIONS BASED ON THEM AND WAYS OF THEIR APPLICATION | 2019 |
|
RU2795229C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2606510C2 |
BIVALENT BROMODOMAIN INHIBITORS AND ROUTES OF USE THEREOF | 2016 |
|
RU2742035C2 |
ION CHANNEL INHIBITORS, PHARMACEUTICAL FORMULATIONS AND APPLICATIONS | 2016 |
|
RU2746188C2 |
QUINAZOLINONE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2017 |
|
RU2730500C2 |
CYANOTHIENOTRIAZOLODIAZEPINES AND METHODS FOR THEIR USE | 2016 |
|
RU2750164C2 |
CONDENSED AZA-HETEROCYCLIC AMIDE COMPOUND AND ITS USE | 2021 |
|
RU2811975C1 |
LEUKOTRIENE A4-HYDROLASE INHIBITORS | 2014 |
|
RU2690489C2 |
GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 |
|
RU2805308C2 |
SPIROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND USE | 2018 |
|
RU2781639C2 |
Authors
Dates
2024-05-02—Published
2021-06-28—Filed